BioSpace News Archive

Policy

Epizyme Submits New Drug Application to the U.S. FDA for Tazemetostat for the Treatment of Patients with Epithelioid Sarcoma

Submission Follows Productive Pre-NDA Meeting and Marks On-time Execution of First of Two NDA Submissions Planned for 2019

May 30, 2019
·
6 min read
Genetown

Thrive Launches with $110 Million Series A Financing to Integrate Earlier Detection of Multiple Cancer Types into Routine Medical Care

Thrive Earlier Detection Corp., a company dedicated to incorporating earlier cancer detection into routine medical care, today launched with $110 million in a Series A financing.

May 30, 2019
·
7 min read
Biotech Beach

Metagenics Announces New Hemp Oil Formula

Metagenics, Inc., a health sciences company, announced the release of its new formula, Hemp Oil, an organic, broad-spectrum hemp extract.

May 30, 2019
·
2 min read
Deals

OTC Markets Group Welcomes Cardiol Therapeutics Inc. to OTCQX

OTC Markets Group Inc., operator of financial markets for 10,000 U.S. and global securities, announced Cardiol Therapeutics Inc., a biotechnology company, has qualified to trade on the OTCQX® Best Market.

May 30, 2019
·
2 min read
Business

Acerus Signs License Agreement to Nasal Technology with University of Texas at Austin

Acerus Pharmaceuticals Corporation announced that it has signed a patent license agreement with the University of Texas at Austin for technology related to the nasal administration of testosterone.

May 30, 2019
·
2 min read
Drug Development

F-star updates on FS118 Clinical Trial and Announces Presentation at ASCO 2019

F-star, a clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy, today provides a Phase 1 clinical update on its wholly-owned lead programme FS118 and announces a presentation at the ASCO Annual Meeting (Chicago, 01 June 2019).

May 30, 2019
·
4 min read
Deals

BiondVax Announces First Quarter 2019 Financial Results

BiondVax Pharmaceuticals Ltd. announced its financial results for the quarter ended March 31, 2019.

May 30, 2019
·
3 min read
Pharm Country

Providing a Critical Roadmap to Bridge the Gap Between Medicine and Public Health

New Case Study from NYU School of Medicine Advances the Field of Population Health

May 30, 2019
·
4 min read
Biotech Beach

Tocagen to Present at Upcoming Jefferies 2019 Healthcare Conference

Tocagen Inc. announced Marty Duvall, chief executive officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6, at 4:00 p.m. ET in New York City.

May 30, 2019
·
1 min read
Drug Development

Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress

Istaroxime Demonstrated Significantly Improved Cardiac Function in Patients with Acute Heart Failure

May 30, 2019
·
7 min read